查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1924734

蛋白質表現和生產服務市場按表達系統、蛋白質類型、應用和最終用戶分類 - 全球預測（2026-2032 年）

Protein Expression & Production Service Market by Expression System, Protein Type, Application, End User - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2025年蛋白質表現和生產服務市值為8.546億美元，預計到2026年將成長至9.3422億美元，預計到2032年將達到16.7804億美元，複合年成長率為10.11%。

主要市場統計數據
基準年 2025 8.546億美元
預計年份：2026年 9.3422億美元
預測年份：2032年 1,678,040,000 美元
複合年成長率 (%) 10.11%

從策略觀點來看，蛋白質表現和生產服務被視為轉化科學、商業生物製劑和診斷創新領域的關鍵平台技術。

蛋白質表現和生產技術在治療藥物研發、診斷技術進步和工業生物技術創新中發揮核心作用。本報告首先著重闡述蛋白質表現技術作為現代生命科學工作流程基礎的重要性，涵蓋從探索性研究到規模化生產的各個環節。報告著重強調了技術選擇（例如表達系統的選擇和平台自動化程度）如何影響下游工藝流程的時間表、可重複性和監管合規性。

技術和營運方面的轉折點正在匯合，推動了表達式平台吞吐量的加速提升、模組化服務模式的建構以及以品質主導的整合。

蛋白質表現和生產領域正經歷一系列變革，重塑其技術、營運和商業性競爭優勢。無細胞系統的進步以及哺乳動物和酵母平台的改進提高了重現性和速度，而自動化平台的日益普及則縮短了實驗週期並提高了通量。此外，高通量篩檢和機器人純化流程的整合正在改變外包與內部能力開發的標準，使得藥物發現工作流程能夠在減少人工干預的情況下實現規模化。

對 2025 年關稅對蛋白質表現和生產服務的採購、供應鏈韌性和籌資策略的影響全面評估。

2025年生效的關稅調整和貿易措施為依賴全球供應鏈獲取蛋白質表現和生產相關試劑、耗材和專用設備的企業帶來了新的挑戰。這些措施的累積影響不僅限於直接成本，還波及籌資策略、庫存管理和地理採購決策。供應商和終端用戶正在積極應對，透過重新評估供應商所在地、探索替代供應商以及加快本地可用材料的認證，來規避單一來源採購的風險。

詳細的細分分析揭示了表達系統、服務類型、蛋白質類別、應用程式和最終用戶如何以獨特的方式影響產能需求和策略重點。

對市場區隔的深入理解揭示了不同表達系統、服務形式、蛋白質類別、應用領域和最終用戶的需求促進因素和產能要求。表達系統選項包括細菌平台（包括革蘭氏陰性菌和革蘭氏陽性菌，它們會影響溶解度和轉譯後修飾策略）；基於大腸桿菌和小麥胚芽的無細胞形式，可實現快速原型製作；適用於複雜折疊和糖基化的昆蟲和哺乳動物系統；以植物細胞培養為中心的植物方法；強調畜牧性表達的基因轉殖基因動物平台以及兼顧基因動物平台；

區域趨勢和能力叢集將影響創新、製造深度和法規環境如何驅動全球市場的採購和夥伴關係策略。

區域趨勢將在決定創新、產能擴張和服務專業化融合的格局方面發揮關鍵作用。美洲擁有密集且成熟的學術機構、生物技術公司和藥物研發生態系統，推動了對先進細胞株開發、高性能自動化平台和大規模生產服務的需求。這種環境促進了合約服務提供者與企業內部團隊之間的夥伴關係，支援快速商業化管道，並著重於監管合規和供應鏈整合。

主要企業的蛋白質表現服務供應商部署的競爭策略和營運差異化措施，旨在整合自動化、擴展服務組合併確保供應鏈可靠性。

蛋白質表現和生產生態系統中的主要企業正專注於一系列策略要務，這些要務強調平台廣度、品質系統和服務整合。市場領導正在投資模組化自動化，以連接髮現和生產階段，從而促進技術轉移並縮短從概念到規模化的週期。許多供應商也正在擴展其服務組合，納入細胞株開發、標記和標記服務以及下游純化等互補能力，以在客戶工作流程中創造更高價值，並減少各階段之間的交接摩擦。

結合自動化、供應鏈多元化、整合服務和合規監管等切實可行的策略措施，以建立永續的競爭優勢。

產業領導者應優先考慮整合科研能力、商業性韌性和以客戶為中心的服務交付的實際措施。首先，加快自動化平台的合格和整合，以減少人工操作造成的變異性並縮短實驗週期。高效能篩檢結合機器人純化技術，可在保持可重複性的同時顯著提高通量。其次，透過供應商多元化和製定區域籌資策略來降低關稅和物流風險。這包括對替代試劑來源合格，並探索關鍵耗材的本地生產夥伴關係。

調查方法結合了第一手訪談、二手證據篩選和嚴格的三角驗證，以得出檢驗的技術和商業性見解。

本分析結合了第一手和第二手研究方法，以確保得出可靠且檢驗的結論。第一手研究包括對學術機構、生物技術負責人、合約研究組織 (CRO)、診斷實驗室和製藥公司的研發、採購和技術總監進行結構化訪談，並輔以與涵蓋表達系統和服務類型的服務供應商的深入討論。從這些對話中獲得的見解為營運重點、挑戰和策略意圖的定性評估提供了依據，並結合了可觀察到的行業趨勢進行驗證。

透過綜合分析技術成熟度、商業性整合和供應鏈韌性，為蛋白質表現和生產相關人員確定策略重點。

總之，蛋白質表現和生產服務環境的特徵是技術快速進步、商業模式不斷演進以及對供應鏈韌性的日益重視。從細菌和無細胞表達系統到先進的哺乳動物和植物表達平台，表達系統的多樣性使得技術相容性和營運靈活性成為決定策略契合度的關鍵因素。能夠成功整合自動化技術、拓展服務範圍並展現監管合規能力的服務供應商，將更有能力為包括學術機構、生物技術創新者、合約研究組織 (CRO)、診斷實驗室和製藥公司在內的各類終端用戶提供最佳服務。

目錄

第1章：序言

第2章調查方法

  • 研究設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查前提
  • 調查限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會地圖
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章 美國關稅的累積影響，2025年

第7章 人工智慧的累積影響，2025年

8. 按表達系統分類的蛋白質表現及生產服務市場

  • 細菌
    • 革蘭氏陰性菌
    • 革蘭氏陽性菌
  • 無細胞
    • 大腸桿菌
    • 小麥胚芽
  • 昆蟲
  • 哺乳動物
  • 植物性
  • 基因改造動物
  • 酵母菌

9. 按蛋白質類型分類的蛋白質表現與生產服務市場

  • 融合蛋白
    • 商品及服務稅標籤
    • 組胺酸標籤
  • 單株抗體
  • 天然蛋白質
  • 重組蛋白
  • 合成蛋白質

第10章：按應用分類的蛋白質表現與生產服務市場

  • 診斷
  • 工業酵素
  • 個人化醫療
  • 研究
  • 治療研發

第11章：按最終用戶分類的蛋白質表現與生產服務市場

  • 學術機構
  • 生技公司
  • 受託研究機構
  • 診斷實驗室
  • 製藥公司

12. 各地區蛋白質表現及生產服務市場

  • 美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：依組別分類的蛋白質表現與生產服務市場

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

14. 各國蛋白質表現與生產服務市場

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

16. 美國蛋白質表現與生產服務市場

第17章：中國蛋白質表現與生產服務市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Agilent Technologies, Inc.
  • Ajinomoto Bio-Pharma Services
  • Aldevron, LLC
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • Charles River Laboratories International, Inc.
  • Creative Biolabs, Inc.
  • Domainex Limited
  • GenScript BIoTech Corporation
  • Iksuda Therapeutics, Inc.
  • Lonza Group AG
  • Merck KGaA
  • Promega Corporation
  • QIAGEN NV
  • Sino Biological, Inc.
  • Sygnature Discovery Ltd.
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
  • VectorBuilder Inc.
  • WuXi Biologics Inc.
Product Code: MRR-7A380DA7C462

The Protein Expression & Production Service Market was valued at USD 854.60 million in 2025 and is projected to grow to USD 934.22 million in 2026, with a CAGR of 10.11%, reaching USD 1,678.04 million by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 854.60 million
Estimated Year [2026] USD 934.22 million
Forecast Year [2032] USD 1,678.04 million
CAGR (%) 10.11%

A strategic orientation that frames protein expression and production services as pivotal enablers of translational science, commercial biologics, and diagnostic innovation

The protein expression and production landscape occupies a central role across therapeutic development, diagnostic advancement, and industrial biotechnology innovation. This report opens with a focused orientation that positions protein expression capabilities as foundational to modern life sciences workflows, from exploratory research to scalable manufacturing. It emphasizes how technical choices-such as the selection of expression systems and the degree of platform automation-influence downstream timelines, reproducibility, and regulatory readiness.

Readers will find a synthesis of operational drivers, technological inflection points, and stakeholder priorities that collectively define strategic decision frameworks. The introduction highlights the interplay between scientific objectives and commercial constraints, noting how R&D teams, contract service providers, and in-house biologics manufacturers prioritize throughput, fidelity, and cost-efficiency differently. This framing sets the stage for deeper analysis of segmentation, regional dynamics, and policy-driven disruptions.

By anchoring the conversation in operational realities and translational goals, the introduction outlines the report's approach to evaluating capabilities, service models, and adoption vectors. It explains how subsequent sections connect laboratory practice with commercial strategy, enabling leaders to assess where investment in expression platforms, automation, or supply chain adjustments will deliver measurable value.

Converging technological and operational inflections that are accelerating throughput, modular service models, and quality-driven integration across expression platforms

The protein expression and production sector is undergoing a set of transformative shifts that are remapping competitive advantage across technical, operational, and commercial dimensions. Advances in cell-free systems and refinements in mammalian and yeast platforms are pushing reproducibility and speed gains, while increased adoption of automation platforms is compressing experimental cycles and elevating throughput. Moreover, integration of high-throughput screening with robotic purification has changed the calculus for outsourcing versus in-house capability development, enabling organizations to scale discovery workflows with fewer manual interventions.

Concurrently, there is growing convergence between synthetic biology approaches and platform engineering, prompting providers to expand services beyond conventional recombinant protein production into areas such as fusion protein engineering and peptidomimetic synthesis. These trends have been accompanied by an intensifying focus on quality attributes that support regulatory pathways and therapeutic translation, driving closer alignment between production processes and downstream analytical validation practices. In addition, commercial pressures-rising demand for personalized medicine inputs and a surge in biologics R&D-are incentivizing modular service models that combine cell line development, custom expression services, and bulk production as integrated offerings.

Taken together, these inflections are reshaping value propositions for service providers, elevating partnerships that can deliver end-to-end workflows, and redefining procurement criteria for academic, biotech, CRO, diagnostic, and pharmaceutical end users.

Comprehensive assessment of how 2025 tariff actions reshaped procurement, supply chain resilience, and sourcing strategies for protein expression and production services

Tariff policy changes and trade actions enacted in 2025 have introduced a new set of considerations for organizations that depend on global supply chains for reagents, consumables, and specialized instrumentation tied to protein expression and production. The cumulative impact of these measures extends beyond direct cost implications to affect procurement strategies, inventory management, and geographic sourcing decisions. Providers and end users have responded by reassessing supplier footprints, seeking alternative vendors, and accelerating qualification of regionally available materials to avoid single-source vulnerabilities.

Logistical friction has also increased lead-time uncertainty for imported components, prompting organizations to enlarge safety stocks for critical reagents and reevaluate just-in-time procurement models. This shift has raised working capital requirements and influenced the timing of large capital equipment purchases, with some organizations preferring local manufacturing or closer regional partnerships to mitigate tariff exposure. Regulatory compliance pathways have become more complex when tariff-driven re-routing affects customs documentation and origin declarations, making coordinated cross-functional engagement between procurement, quality assurance, and regulatory teams essential.

In response, contract providers have adapted commercial terms, introduced tariff-pass-through clauses in service agreements, and in some cases localized downstream services to preserve competitiveness. The broader implication is an acceleration of strategic nearshoring and supplier diversification, where resilience and supply certainty are increasingly prioritized alongside traditional performance metrics like yield and purity.

Deep segmentation analysis revealing how expression systems, service types, protein classes, applications, and end users uniquely shape capability demands and strategic priorities

A nuanced understanding of market segmentation reveals distinct demand drivers and capability requirements across expression systems, service types, protein classes, applications, and end users. Expression system choices include bacterial platforms, with Gram-negative and Gram-positive subdivisions that influence solubility and post-translational modification strategies; cell-free formats including E. coli-based and wheat germ-based systems that offer rapid prototyping; insect and mammalian systems that are favored for complex folding and glycosylation; plant-based approaches centered on plant cell cultures; transgenic animal routes that emphasize livestock expression; and yeast platforms that balance scalability with eukaryotic processing.

Service-type segmentation spans automated platforms that combine high-throughput screening with robotic purification capabilities, bulk production services optimized for larger batch runs, cell line development workflows that secure long-term production stability, and custom protein expression offerings that often include labeling services and tagged protein delivery to meet specific experimental needs. Protein-type distinctions matter operationally: fusion proteins, with common variants such as GST-tagged and His-tagged constructs, are designed for ease of purification and functional studies; monoclonal antibodies demand rigorous process control for therapeutic applications; native and recombinant proteins serve diverse research and diagnostic purposes; and synthetic proteins, including peptidomimetics, are increasingly important for targeted modalities.

Application-oriented segmentation encompasses diagnostics, industrial enzymes, personalized medicine, research, and therapeutic development, each with unique regulatory and scalability requirements. End users range from academic institutions that prioritize flexibility and cost-effectiveness, to biotechnology companies and pharmaceutical firms focused on translational throughput and compliance, to contract research organizations and diagnostic labs that require robust quality systems and reproducible delivery. Understanding how these segments intersect clarifies where investments in automation, platform diversity, or specialized services will yield the greatest strategic return.

Regional dynamics and capability clusters that determine how innovation, manufacturing depth, and regulatory environments drive sourcing and partnership strategies across global markets

Regional dynamics play a decisive role in shaping where innovation, capacity expansion, and service specialization coalesce. The Americas present a mature ecosystem with a dense concentration of academic institutions, biotechnology companies, and pharmaceutical developers, driving demand for advanced cell line development, high-throughput automated platforms, and large-scale production services. This environment encourages partnerships between contract providers and in-house teams, and supports rapid commercialization pathways that emphasize regulatory readiness and supply chain integration.

Europe, Middle East & Africa display a heterogeneous landscape where pockets of scientific excellence coexist with regions focused on cost-efficient manufacturing and localized diagnostic needs. Here, regulatory frameworks and public procurement priorities influence service design, incentivizing providers to offer flexible customization and compliance-oriented workflows. Cross-border collaboration within the region has facilitated shared infrastructure approaches that reduce barriers for smaller biotech ventures while enabling larger firms to leverage regional specialty capabilities.

Asia-Pacific continues to expand both capacity and technical sophistication, with growing investment in mammalian systems, yeast-based production, and localized reagent manufacturing. Industrial-scale enzyme production and contract manufacturing services are particularly prominent, and the region's manufacturing depth supports shorter lead times for equipment and consumables. Across all regions, strategic considerations such as tariff exposure, talent availability, and the maturity of local regulatory pathways inform decisions about where to locate critical capabilities and which partnerships to prioritize.

Competitive strategies and operational differentiators that leading firms deploy to integrate automation, broaden service portfolios, and secure supply chain reliability in protein expression services

Leading companies in the protein expression and production ecosystem are converging around a set of strategic imperatives that emphasize platform breadth, quality systems, and service integration. Market leaders are investing in modular automation that bridges discovery and production phases, enabling smoother technology transfer and reducing cycle times from concept to scale. Many providers are also expanding service portfolios to include complementary capabilities-such as cell line development, labeling and tag services, and downstream purification-to capture higher value across client workflows and reduce friction during handoffs between stages.

Strategic partnerships and co-development agreements have become common as firms seek to combine specialized technical know-how with broader commercial reach. Firms that prioritize traceable quality systems and robust documentation practices position themselves favorably for therapeutics and diagnostics clients with stringent regulatory expectations. Additionally, firms that offer flexible commercial models, including project-based scopes, subscription access to data portals, and tiered service levels, are better able to serve diverse end users from academic researchers to large pharmaceutical companies.

Operationally, investments in supply chain transparency, vendor qualification, and regional service hubs are differentiators in an environment where sourcing certainty matters. Companies that align technical capabilities with responsive customer engagement models-offering consultative design, rapid prototyping, and scale-up support-are increasingly perceived as strategic partners rather than transactional vendors.

Practical strategic actions leaders should implement to combine automation, supply diversification, integrated services, and regulatory readiness for durable competitive advantage

Industry leaders should prioritize a set of actionable initiatives that align scientific capability with commercial resilience and customer-centric delivery. First, accelerate qualification and integration of automated platforms to reduce manual variability and shorten experimental cycles; pairing high-throughput screening with robotic purification will materially improve throughput while maintaining reproducibility. Second, diversify supplier bases and develop regional sourcing strategies to mitigate tariff and logistics risks, including qualification of alternative reagent sources and exploring local manufacturing partnerships for critical consumables.

Third, broaden service offerings to provide end-to-end solutions that combine cell line development, custom expression options with labeling and tagged protein services, and scalable bulk production. This integrated approach increases customer retention and simplifies project management across client organizations. Fourth, strengthen quality management systems and regulatory readiness to better support therapeutic and diagnostic customers; invest in documentation, validation pathways, and personnel training to meet evolving compliance expectations. Fifth, engage in targeted collaborations with academic centers, biotech innovators, and CROs to co-develop specialized products such as fusion proteins, monoclonal antibody workflows, and peptidomimetic synthesis capabilities that address emerging application needs.

Finally, implement flexible commercial arrangements-including tiered pricing, subscription models, and bespoke data-services-that align value creation with client budgets and timelines. These steps, taken in combination, will reinforce competitive positioning and support sustainable growth in a rapidly evolving landscape.

Methodological framework combining primary interviews, secondary evidence triage, and rigorous triangulation to produce validated insights across technical and commercial dimensions

This analysis synthesizes primary and secondary research methodologies to ensure robust, verifiable insights. Primary inputs included structured interviews with R&D leaders, procurement officers, and technical heads across academic institutions, biotech firms, CROs, diagnostic labs, and pharmaceutical companies, supplemented by in-depth discussions with service providers across expression systems and service types. These conversations informed qualitative assessments of operational priorities, pain points, and strategic intent, and were triangulated with observable industry behavior.

Secondary research encompassed rigorous review of peer-reviewed publications, regulatory guidance, patent filings, and company disclosures that pertain to expression technologies, automation adoption, and supply chain practices. The research team applied cross-validation techniques to reconcile interview findings with documented evidence, emphasizing reproducibility and methodological transparency. Segmentation was defined to reflect actionable distinctions: expression systems (including bacterial, cell-free, insect, mammalian, plant-based, transgenic animal, and yeast), service types (from automated platforms to custom protein expression), protein types (including fusion constructs and synthetic peptides), applications, and end-user categories.

Analytical steps involved process mapping, capability gap analysis, and thematic synthesis to identify recurring patterns and strategic inflection points. Limitations and potential biases were addressed through respondent diversity and iterative validation rounds, ensuring conclusions reflect a balanced and contemporary view of the protein expression and production services landscape.

A synthesis that connects technological maturity, commercial integration, and supply resilience to define strategic priorities for protein expression and production stakeholders

In conclusion, the protein expression and production services environment is defined by accelerating technological refinement, evolving commercial models, and heightened attention to supply chain resilience. Expression system diversity-from bacterial and cell-free approaches through advanced mammalian and plant-based platforms-creates a landscape where technical fit and operational agility determine strategic suitability. Service providers that successfully integrate automation, broaden their service portfolios, and demonstrate regulatory readiness will be best positioned to serve the wide spectrum of end users, including academic institutions, biotech innovators, CROs, diagnostic labs, and pharmaceutical companies.

Tax and trade policy shifts, including tariff actions in 2025, have underscored the importance of supplier diversification and regional capacity planning, making procurement strategy a core component of competitive differentiation. Looking forward, the most successful organizations will be those that align scientific excellence with resilient commercial architectures-investing in modular automation, platform interoperability, and customer-centric service design. Collectively, these elements will support more predictable translation from discovery to application and strengthen the role of protein expression services as enablers of therapeutic, diagnostic, and industrial innovation.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Protein Expression & Production Service Market, by Expression System

  • 8.1. Bacteria
    • 8.1.1. Gram Negative
    • 8.1.2. Gram Positive
  • 8.2. Cell Free
    • 8.2.1. E Coli Based
    • 8.2.2. Wheat Germ Based
  • 8.3. Insect
  • 8.4. Mammalian
  • 8.5. Plant Based
  • 8.6. Transgenic Animal
  • 8.7. Yeast

9. Protein Expression & Production Service Market, by Protein Type

  • 9.1. Fusion Protein
    • 9.1.1. GST Tagged
    • 9.1.2. His Tagged
  • 9.2. Monoclonal Antibody
  • 9.3. Native Protein
  • 9.4. Recombinant Protein
  • 9.5. Synthetic Protein

10. Protein Expression & Production Service Market, by Application

  • 10.1. Diagnostics
  • 10.2. Industrial Enzymes
  • 10.3. Personalized Medicine
  • 10.4. Research
  • 10.5. Therapeutic Development

11. Protein Expression & Production Service Market, by End User

  • 11.1. Academic Institutions
  • 11.2. Biotechnology Companies
  • 11.3. Contract Research Organizations
  • 11.4. Diagnostic Labs
  • 11.5. Pharmaceutical Companies

12. Protein Expression & Production Service Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Protein Expression & Production Service Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Protein Expression & Production Service Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Protein Expression & Production Service Market

16. China Protein Expression & Production Service Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Agilent Technologies, Inc.
  • 17.6. Ajinomoto Bio-Pharma Services
  • 17.7. Aldevron, LLC
  • 17.8. Bio-Rad Laboratories, Inc.
  • 17.9. Bio-Techne Corporation
  • 17.10. Charles River Laboratories International, Inc.
  • 17.11. Creative Biolabs, Inc.
  • 17.12. Domainex Limited
  • 17.13. GenScript Biotech Corporation
  • 17.14. Iksuda Therapeutics, Inc.
  • 17.15. Lonza Group AG
  • 17.16. Merck KGaA
  • 17.17. Promega Corporation
  • 17.18. QIAGEN N.V.
  • 17.19. Sino Biological, Inc.
  • 17.20. Sygnature Discovery Ltd.
  • 17.21. Takara Bio Inc.
  • 17.22. Thermo Fisher Scientific Inc.
  • 17.23. VectorBuilder Inc.
  • 17.24. WuXi Biologics Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM NEGATIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GRAM POSITIVE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY E COLI BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY WHEAT GERM BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INSECT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MAMMALIAN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PLANT BASED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY TRANSGENIC ANIMAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY YEAST, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GST TAGGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY HIS TAGGED, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY MONOCLONAL ANTIBODY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY NATIVE PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RECOMBINANT PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SYNTHETIC PROTEIN, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY INDUSTRIAL ENZYMES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PERSONALIZED MEDICINE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY RESEARCH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY ACADEMIC INSTITUTIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CONTRACT RESEARCH ORGANIZATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY DIAGNOSTIC LABS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PHARMACEUTICAL COMPANIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 95. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 96. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 97. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 98. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 99. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 100. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 101. AMERICAS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 102. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 104. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 105. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 106. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 107. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 108. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 109. NORTH AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 110. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 112. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 113. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 114. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 115. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 116. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 117. LATIN AMERICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 118. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 119. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 120. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 121. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 122. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 123. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 124. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 126. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 127. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 128. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 129. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 130. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 132. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 133. EUROPE PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 134. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 135. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 136. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 137. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 138. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 139. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 140. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 141. MIDDLE EAST PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 142. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 144. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 145. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 146. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 148. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 149. AFRICA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 150. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 151. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 152. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 153. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 154. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 155. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 156. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. ASIA-PACIFIC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 161. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 162. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 163. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 164. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 165. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 166. ASEAN PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 168. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 169. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 170. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 171. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 172. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 173. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 174. GCC PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPEAN UNION PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 183. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 185. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 186. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 187. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 188. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 189. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 190. BRICS PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 191. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 192. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 193. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 194. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 195. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 196. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 197. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 198. G7 PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 199. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 201. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 202. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 203. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 204. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 205. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 206. NATO PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 208. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 209. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 210. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 211. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 212. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 213. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 214. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 215. UNITED STATES PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 216. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 217. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY EXPRESSION SYSTEM, 2018-2032 (USD MILLION)
  • TABLE 218. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY BACTERIA, 2018-2032 (USD MILLION)
  • TABLE 219. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY CELL FREE, 2018-2032 (USD MILLION)
  • TABLE 220. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY PROTEIN TYPE, 2018-2032 (USD MILLION)
  • TABLE 221. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY FUSION PROTEIN, 2018-2032 (USD MILLION)
  • TABLE 222. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 223. CHINA PROTEIN EXPRESSION & PRODUCTION SERVICE MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)